Device Trial Radar · NCT07817784
Indonesian Version of Oxford Cognitive Screen-Plus Test in Stroke Patient
Last checked: Nov 19, 2026Latest source record: Sep 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
75
Planned (sponsor's estimate)
Start
Sep 1, 2026
Primary completion
Oct 1, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Universitas PadjadjaranAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Oxford
- First posted
- Sep 14, 2026
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The incidence of stroke increases every year throughout the world. Neuropsychological assessment is the best way to identify post-stroke cognitive dysfunction. The importance of cognitive function in the post stroke rehabilitation program process requires a tool that can detect cognitive disorders more specifically and more sensitively. The investigator aim in this study was to develop Indonesian version of the OCS - Plus among stroke patient in Indonesia.
Conditions
- Post Stroke
- Cognitive Assessment
Interventions
OCS Plus AssessmentDevice
Subject is going to carry out Indonesian OCS Plus assessment in accordance with the procedure given by the application.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Validity and Reliability of Indonesian OCS PlusTime frame: T0 - Baseline assessment (Day 1) -. Informed consent and Demographic -. MoCA-Ina -. Indonesian OCS-Plus T1 - Retest (48 hours after T0) -.Indonesian OCS-Plus repeated under standardized conditions -.No cognitive rehabilitation intervention between T0-T1
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.